Role of Epigenetics in Female Genital Tuberculosis patients
Phase 4
- Conditions
- Health Condition 1: N739- Female pelvic inflammatory disease, unspecifiedHealth Condition 2: N738- Other specified female pelvic inflammatory diseases
- Registration Number
- CTRI/2019/12/022285
- Lead Sponsor
- Ministry of Health and Family Welfare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
female infertile patients attending GOPD for Infertility treatment
Exclusion Criteria
Failure to meet all inclusion criteria
Women having any gynecological malignancy
Retreatment cases of FGTB
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To elucidate the diagnostic modality for female genital tuberculosisTimepoint: after 2 years
- Secondary Outcome Measures
Name Time Method to correlate the clinical outcome of the study with the clinico-pathological condition of the diseaseTimepoint: after 3 years